Form 4 for URGN UroGen Pharma Ltd.
Accepted 2022-09-02 00:00:00 ET · period of report 2022-08-31 · accession 0001437749-22-021777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-02 | 2022-08-31 | URGN | Belldegrun Arie | Dir | M - OptEx | $5.00 | +3,241 | 248.7K | +1% | +$16.2K |
| D | 2022-09-02 | 2022-08-31 | URGN | Belldegrun Arie | Dir | M - OptEx | $0.00 | -3,241 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-08-31 | M | A | 3,241 | $5.00 | 248,693 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-08-31 | M | D | 3,241 | $0.00 | 0 | D | $5.00 · 2015-09-01 to 2022-09-01 | 3,241 Ordinary Shares |